These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22635217)

  • 21. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential failure of the International Normalized Ratio (INR) System in the monitoring of oral anticoagulation in patients with lupus anticoagulants.
    Della Valle P; Crippa L; Safa O; Tomassini L; Pattarini E; Vigano-D'Angelo S; Grazia Sabbadini M; D'Angelo A
    Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():10-4. PubMed ID: 8952752
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current management of antiphospholipid syndrome-related thrombosis.
    Puente D; Pombo G; Forastiero R
    Expert Rev Cardiovasc Ther; 2009 Dec; 7(12):1551-8. PubMed ID: 19954317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards evidence-based treatment of thrombotic antiphospholipid syndrome.
    Derksen RH; de Groot PG
    Lupus; 2010 Apr; 19(4):470-4. PubMed ID: 20353990
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome.
    Pengo V; Ruffatti A; Legnani C; Gresele P; Barcellona D; Erba N; Testa S; Marongiu F; Bison E; Denas G; Banzato A; Padayattil Jose S; Iliceto S
    J Thromb Haemost; 2010 Feb; 8(2):237-42. PubMed ID: 19874470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence based treatment of the antiphospholipid syndrome II. Optimal anticoagulant therapy for thrombosis.
    Crowther MA; Wisloff F
    Thromb Res; 2005; 115(1-2):3-8. PubMed ID: 15567446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism.
    Veeger NJ; Piersma-Wichers M; Tijssen JG; Hillege HL; van der Meer J
    Br J Haematol; 2005 Feb; 128(4):513-9. PubMed ID: 15686461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current strategies in prophylaxis and treatment of venous thromboembolism.
    Schulman S
    Ann Med; 2008; 40(5):352-9. PubMed ID: 18484347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Thrombophilia and principle of thrombosis prevention in obstetrics].
    Sin'kov SV; Zabolotskikh IB; Penzhoian GA; Muzychenko VP
    Anesteziol Reanimatol; 2011; (2):66-70. PubMed ID: 21692222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A retrospective review of 61 patients with antiphospholipid syndrome. Analysis of factors influencing recurrent thrombosis.
    Krnic-Barrie S; O'Connor CR; Looney SW; Pierangeli SS; Harris EN
    Arch Intern Med; 1997 Oct; 157(18):2101-8. PubMed ID: 9382667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
    Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
    Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiphospholipid antibiodies: a critical review of the literature.
    Lim W; Crowther MA
    Curr Opin Hematol; 2007 Sep; 14(5):494-9. PubMed ID: 17934356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiphospholipid syndrome: an evolving story.
    Robertson B; Greaves M
    Blood Rev; 2006 Jul; 20(4):201-12. PubMed ID: 16442679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antiphospholipid syndrome: from diagnosis to treatment].
    Martinović D; Radić M; Fabijanić D; Fabijanić A
    Lijec Vjesn; 2007; 129(8-9):281-5. PubMed ID: 18198628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How much warfarin is enough in APS related thrombosis?
    Erkan D; Lockshin MD
    Thromb Res; 2004; 114(5-6):435-42. PubMed ID: 15507275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical manifestations and outcomes of antithrombotic treatment of the Tan Tock Seng Hospital Singapore antiphospholipid syndrome cohort.
    Tan BE; Thong BY; Shivananda S; Han WW; Chng HH
    Lupus; 2009 Jul; 18(8):752-8. PubMed ID: 19502274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Venous thromboembolism prophylaxis after major orthopaedic surgery: a pooled analysis of randomized controlled trials.
    Brown GA
    J Arthroplasty; 2009 Sep; 24(6 Suppl):77-83. PubMed ID: 19628366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stroke and antiphospholipid syndrome: the treatment debate.
    Ruiz-Irastorza G; Khamashta MA
    Rheumatology (Oxford); 2005 Aug; 44(8):971-4. PubMed ID: 15840602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of deep vein thrombosis in cancer patients.
    Lee AY
    Semin Thromb Hemost; 2007 Oct; 33(7):699-706. PubMed ID: 18000798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of venous thromboembolism in orthopedic surgery with vitamin K antagonists: a meta-analysis.
    Mismetti P; Laporte S; Zufferey P; Epinat M; Decousus H; Cucherat M
    J Thromb Haemost; 2004 Jul; 2(7):1058-70. PubMed ID: 15219187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.